Agoracom: Small Cap Investment - Resverlogix Corp.

Dec 04, 2020 09:09AM

Re: Which BP

paladin

Dec 04, 2020 09:29AM

To our scientist

Dec 05, 2020 01:19AM

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: To our scientist

in response to

To our scientist

https://www.resverlogix.com/upload/media_element/202/0fe84959b9a4/betonmace-post-aha-presentation-final.pdf

posted on Dec 05, 2020 10:03AM

This may give up a clue:

Critically Important Finding, Patents Filed – Potential Synergy with New Generation of Diabetes Drugs (SLIDE 3)

– Primary Endpoint in Patients Receiving SGLT2i

• All SGLT2i’s: 60% Hazard Reduction (95% CI; 0.16-1.00) p=0.05 (non-QC’d)

• Empagliflozin: 66% Hazard Reduction (95% CI; 0.12-1.01) p=0.05 (non-QC’d)

Empagliflozin, sold under the brand name Jardiance among others.

Koo

5 Recommendations

Dec 05, 2020 02:02PM

Dec 05, 2020 02:28PM

cityslicker99

Dec 07, 2020 05:32PM

Dec 07, 2020 07:41PM

Dec 07, 2020 07:46PM

Dec 07, 2020 07:56PM

Dec 07, 2020 07:59PM

Dec 07, 2020 09:12PM

Dec 07, 2020 10:25PM

Dec 07, 2020 10:31PM

Dec 07, 2020 11:15PM